The effect of L-arabinose on glycaemic responses in subjects at risk of developing type II diabetes - Ara4-study

Wageningen Universiteit0 个研究点目标入组 18 人开始时间: 待定最近更新: 2024年4月15日

适应症

试验速览

暂无简介。

•* Diagnosed diabetes,
•* Diagnosed liver, pancreas or endocrine diseases which could affect the study results,
•* Having gastro-intestinal problems,
•* Use of medication or supplements which could affect the study results (Moreover, chronic medication and supplements should be used as normal when they donot affect the study results),
•* Allergy, intolerance or oversensitivity for food products,
•* Sensitive to medical skin adhesives,
•* Following a medically prescribed, low energy or low carbohydrate diet,
•* Unwilling to consume the provided diets,
•* >5 kg weight change during the last 3 months,
•* Current antibiotics usage or in the two months prior to the screening session,
•* Excessive alcohol consumption (>21 glasses/week on average for men and >14 glasses/week for women),
•* Having blood vessels that are too difficult for inserting a cannula, as judged by the study nurse,
•* Not normal haemoglobin (Hb) concentration: <8.5 mmol/L for men and <7.5 mmol/L for women,
•* Recent blood donation (<1 month prior to the first study day),
•* Planning to donate blood as a blood donor during the study,
•* Mental status that is incompatible with the conduct of the study,
•* Being an employee of Wageningen University, division of Human Nutrition and Health,
•* Current participation in other research (except EetMeetWeet).

发起方